These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10680703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Leder LD, Schaefer HE.
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [Abstract] [Full Text] [Related]

  • 6. Reversal of myelofibrosis by hydroxyurea.
    Löfvenberg E, Wahlin A, Roos G, Ost A.
    Eur J Haematol; 1990 Jan; 44(1):33-8. PubMed ID: 2307218
    [Abstract] [Full Text] [Related]

  • 7. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C, Pieri L, Paoli C, Daniele G, Lasho T, Tefferi A, Vannucchi AM.
    Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha.
    Messora C, Bensi L, Vecchi A, Longo R, Giacobbi F, Temperani P, Bevini M, Emilia G, Sacchi S.
    Br J Haematol; 1994 Feb; 86(2):402-4. PubMed ID: 8199036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?
    Brandt L, Anderson H.
    Eur J Haematol; 1995 Jan; 54(1):21-6. PubMed ID: 7859872
    [Abstract] [Full Text] [Related]

  • 17. Can pegylated interferon improve the outcome of polycythemia vera patients?
    Crisà E, Cerrano M, Beggiato E, Benevolo G, Lanzarone G, Manzini PM, Borchiellini A, Riera L, Boccadoro M, Ferrero D.
    J Hematol Oncol; 2017 Jan 13; 10(1):15. PubMed ID: 28086927
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
    Tefferi A, Elliott MA, Kao PC, Yoon S, El-Hemaidi I, Pearson TC.
    Blood; 2000 Aug 15; 96(4):1582-4. PubMed ID: 10942409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.